Abstract:Mycobacteria have
a distinctive glycolipid-rich outer membrane,
the mycomembrane, which is a critical target for tuberculosis drug
development. However, proteins that associate with the mycomembrane,
or that are involved in its metabolism and host interactions, are
not well-characterized. To facilitate the study of mycomembrane-related
proteins, we developed photoactivatable trehalose monomycolate analogues
that metabolically incorporate into the mycomembrane in live mycobacteria,
enabling in vivo photo-cross-… Show more
“…Likewise, chemical probes for detecting direct interactions between proteins in the mycobacterial cell envelope have been coupled to quantitative proteomics. These approaches have revealed more than 100 envelope proteins and their binding partners in M. smegmatis [134]. Another interesting example of the genetic proteome is a recent study in which genetics were used to alter the proteome of microvesicles produced by M. tuberculosis.…”
Section: The Genetic Proteome Defines Secreted and Cell Wall-associatmentioning
Mycobacterial pathogens pose a sustained threat to human health. There is a critical need for new diagnostics, therapeutics, and vaccines targeting both tuberculous and nontuberculous mycobacterial species. Understanding the basic mechanisms used by diverse mycobacterial species to cause disease will facilitate efforts to design new approaches toward detection, treatment, and prevention of mycobacterial disease. Molecular, genetic, and biochemical approaches have been widely employed to define fundamental aspects of mycobacterial physiology and virulence. The recent expansion of genetic tools in mycobacteria has further increased the accessibility of forward genetic approaches. Proteomics has also emerged as a powerful approach to further our understanding of diverse mycobacterial species. Detection of large numbers of proteins and their modifications from complex mixtures of mycobacterial proteins is now routine, with efforts of quantification of these datasets becoming more robust. In this review, we discuss the “genetic proteome,” how the power of genetics, molecular biology, and biochemistry informs and amplifies the quality of subsequent analytical approaches and maximizes the potential of hypothesis-driven mycobacterial research. Published proteomics datasets can be used for hypothesis generation and effective post hoc supplementation to experimental data. Overall, we highlight how the integration of proteomics, genetic, molecular, and biochemical approaches can be employed successfully to define fundamental aspects of mycobacterial pathobiology.
“…Likewise, chemical probes for detecting direct interactions between proteins in the mycobacterial cell envelope have been coupled to quantitative proteomics. These approaches have revealed more than 100 envelope proteins and their binding partners in M. smegmatis [134]. Another interesting example of the genetic proteome is a recent study in which genetics were used to alter the proteome of microvesicles produced by M. tuberculosis.…”
Section: The Genetic Proteome Defines Secreted and Cell Wall-associatmentioning
Mycobacterial pathogens pose a sustained threat to human health. There is a critical need for new diagnostics, therapeutics, and vaccines targeting both tuberculous and nontuberculous mycobacterial species. Understanding the basic mechanisms used by diverse mycobacterial species to cause disease will facilitate efforts to design new approaches toward detection, treatment, and prevention of mycobacterial disease. Molecular, genetic, and biochemical approaches have been widely employed to define fundamental aspects of mycobacterial physiology and virulence. The recent expansion of genetic tools in mycobacteria has further increased the accessibility of forward genetic approaches. Proteomics has also emerged as a powerful approach to further our understanding of diverse mycobacterial species. Detection of large numbers of proteins and their modifications from complex mixtures of mycobacterial proteins is now routine, with efforts of quantification of these datasets becoming more robust. In this review, we discuss the “genetic proteome,” how the power of genetics, molecular biology, and biochemistry informs and amplifies the quality of subsequent analytical approaches and maximizes the potential of hypothesis-driven mycobacterial research. Published proteomics datasets can be used for hypothesis generation and effective post hoc supplementation to experimental data. Overall, we highlight how the integration of proteomics, genetic, molecular, and biochemical approaches can be employed successfully to define fundamental aspects of mycobacterial pathobiology.
“…However, its protein composition has eluded classic biochemical techniques for a long time, in part because of the difficulty of cleanly separating the covalently bound mycomembrane from other layers of the complex mycobacterial envelope. Kavunja et al recently developed the first photocrosslinking probes for the mycomembrane to analyze mycolate-protein interactions in vivo (Figure 2E) (Kavunja et al, 2020). They synthesized a TMM analog that specifically incorporates into the TDM portion of the mycomembrane via previously reported conserved, substrate-promiscuous Ag85 mycoloyltransferases (Fiolek et al, 2019).…”
Section: Metabolic Incorporation Of Photocrosslinking Sugarsmentioning
confidence: 99%
“…Previously, Sarkar et al exploited the MurF ligation process to insert a D-Ala-that was biofunctionalized with an alkyne and photocrosslinking handles into Lipid II to mine the protein-interacting partners (Sarkar et al, 2016). Targeted acquisition of cell envelope interactomes may reveal new potential targets for antibiotic therapies (Kavunja et al, 2020).…”
Section: Metabolic Incorporation Of Photocrosslinking Sugarsmentioning
Bacteria surround themselves with cell walls to maintain cell rigidity and protect against environmental insults. Here we review chemical and biochemical techniques employed to study bacterial cell wall biogenesis. Recent advances including the ability to isolate critical intermediates, metabolic approaches for probe incorporation, and isotopic labeling techniques have provided critical insight into the biochemistry of cell walls. Fundamental manuscripts that have used these techniques to discover cell wall-interacting proteins, flippases, and cell wall stoichiometry are discussed in detail. The review highlights that these powerful methods and techniques have exciting potential to identify and characterize new targets for antibiotic development. ll ll
“…Glycans are vital in a broad range of processes, their direct recognition by glycan-binding proteins is important for many processes that may be essential and druggable. Recently, Kavunja et al used a glycomics approach to identify mycolate-interacting proteins associated with synthesis and remodeling of the membrane in M. smegmatis that could lead to the validation of novel therapeutic targets [111]. Such techniques offer unique opportunities for biological discovery and new target identification that will expand as methodologies develop to increase sensitivity and reduce complexity.…”
Multi-omics strategies are indispensable tools in the search for new anti-tuberculosis drugs. Omics methodologies, where the ensemble of a class of biological molecules are measured and evaluated together, enable drug discovery programs to answer two fundamental questions. Firstly, in a discovery biology approach, to find new targets in druggable pathways for target-based investigation, advancing from target to lead compound. Secondly, in a discovery chemistry approach, to identify the mode of action of lead compounds derived from high-throughput screens, progressing from compound to target. The advantage of multi-omics methodologies in both of these settings is that omics approaches are unsupervised and unbiased to a priori hypotheses, making omics useful tools to confirm drug action, reveal new insights into compound activity, and discover new avenues for inquiry. This review summarizes the application of Mycobacterium tuberculosis omics technologies to the early stages of tuberculosis antimicrobial drug discovery.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.